Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis
about
PET/CT imaging of Mycobacterium tuberculosis infectionTuberculosis vaccines and prevention of infectionData needs for evidence-based decisions: a tuberculosis modeler's 'wish list'The ongoing challenge of latent tuberculosisTuberculosis vaccines: barriers and prospects on the quest for a transformative toolMDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosisA Novel Tool Improves Existing Estimates of Recent Tuberculosis Transmission in Settings of Sparse Data CollectionThe Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical ModellingSafety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis.Tuberculosis in tropical areas and immigrants.A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis.DNA immunization of Mycobacterium tuberculosis resuscitation-promoting factor B elicits polyfunctional CD8(+) T cell responses.Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults.Modeling the impact of novel diagnostic tests on pediatric and extrapulmonary tuberculosis.How much is tuberculosis screening worth? Estimating the value of active case finding for tuberculosis in South Africa, China, and India.Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus.Population-level impact of same-day microscopy and Xpert MTB/RIF for tuberculosis diagnosis in Africa.Population-level impact of active tuberculosis case finding in an Asian megacity.Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis.Modeling the potential impact of host population survival on the evolution of M. tuberculosis latency.Tuberculosis prevention in South AfricaHuman and Murine Clonal CD8+ T Cell Expansions Arise during Tuberculosis Because of TCR SelectionTuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation diseaseRisk for Tuberculosis Disease Among Contacts with Prior Positive Tuberculin Skin Test: A retrospective Cohort Study, New York City.Modelling challenges in context: lessons from malaria, HIV, and tuberculosisDistribution and transmission of Mycobacterium tuberculosis complex lineages among children in peri-urban Kampala, Uganda.The Risk of Tuberculosis Reinfection Soon after Cure of a First Disease Episode Is Extremely High in a Hyperendemic Community.TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection.Molecular epidemiology of HIV-associated tuberculosis in Dar es Salaam, Tanzania: strain predominance, clustering, and polyclonal diseaseThe impact of new tuberculosis diagnostics on transmission: why context matters.A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents.Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and controlBurden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis.Recurrent tuberculosis risk among HIV-infected adults in Tanzania with prior active tuberculosisTuberculosis in Cape Town: An age-structured transmission model.The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study.Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, India.BCG and New Preventive Tuberculosis Vaccines: Implications for Healthcare Workers.Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis.
P2860
Q26748493-223179FA-E341-4D57-9E14-3EAD55BD3F0DQ26782022-6B9726FB-2497-4B77-87EA-A8128344A6C2Q27015848-CB7AA077-F5A8-4573-A559-173FF3CFD053Q28386135-5DD0F717-267F-45FF-9684-FC53F250E76BQ28390218-6D04F37C-D003-4E00-8216-71D89B08293AQ29247878-0B620AA7-011A-4D7A-B66E-5F3CA231A76BQ30000004-EF142D92-A076-4FDC-9294-5BBFDB7B85FEQ30244104-C1691216-6642-46FC-896E-BCCC1F486686Q33675370-1ABA3219-ADF5-4C3E-907A-21DB7FE71C1AQ33719289-CF791B0F-2969-484D-8BAD-0378BF470B7DQ33778365-1480A9D7-A054-4408-895C-B4164D6D2C5DQ33847279-C10B65C2-6116-45EA-A280-8D0D5DE2C30DQ33850516-CD846332-BFD6-47B1-8675-8D3EB15CABAEQ34055234-E23CF3B4-E472-476F-98FD-3A27A5D96B51Q34208001-E041EDCE-A72D-48D2-8DA7-B1431392C7C7Q34474397-B0D16037-F92E-4CE2-B3F9-B916E0760603Q34603687-36B7EC30-7727-4672-8FF0-7C21F248DF31Q34947034-9C51E839-F7FA-4276-94BE-6F9C69BF9365Q35023186-DB90F600-7170-4B37-A78A-EB25394554BDQ35166484-D986AC8F-4E81-431E-8353-83C3731A9B0CQ35232078-CA8836BA-BC98-4D25-852C-BF046E1B08A9Q35304473-C21E91D4-EDBF-4E87-8922-AA5566FA3BA5Q35577267-EE132569-36ED-4543-965F-25A370D810B4Q35584122-6A36C446-F708-485E-B284-F4B385A37520Q35638226-BD688293-64F0-4F5B-B5EC-F0049B4D9DFDQ35671092-2D36FAF7-24EE-46FB-A7A0-F36D9D942153Q35794495-8081A1C8-DDAF-42F0-A9B7-029DAB2527E3Q35864014-12E151B1-B558-4D7F-9826-5D80FC341ED0Q35954111-26F233FD-D54B-4022-975F-E7EE7A5FE534Q36171368-B0F39E8B-3404-4A28-82E0-FD6467C2A589Q36316501-824CC41D-927B-4FF0-A3A9-A6B3CB969B10Q36338571-D86AA7DC-589F-4C1E-B4B6-BA0C260D7CF8Q36361918-E36EA570-9736-4A5E-B416-54D72784F10DQ36386227-F9E7B1A3-D1E0-41F6-B6B7-229290D8F59FQ36457649-7A111D64-8BFB-4417-AFEB-6BCAF812C587Q36686287-54AEFDA1-F81D-4D90-A5CB-EADFDF5A5B21Q36720436-03F8107E-F77E-4521-BF93-BA5EB256BEAFQ36832024-08903CDB-1359-4E68-A81E-DFA83493CF00Q36838289-57B22301-07F1-4172-943F-505AFBF5790FQ37021617-85B68F89-EB29-42DF-A5F1-068DAEF1CAE2
P2860
Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Risk of progression to active ...... ith Mycobacterium tuberculosis
@ast
Risk of progression to active ...... ith Mycobacterium tuberculosis
@en
type
label
Risk of progression to active ...... ith Mycobacterium tuberculosis
@ast
Risk of progression to active ...... ith Mycobacterium tuberculosis
@en
prefLabel
Risk of progression to active ...... ith Mycobacterium tuberculosis
@ast
Risk of progression to active ...... ith Mycobacterium tuberculosis
@en
P2093
P2860
P50
P356
P1476
Risk of progression to active ...... ith Mycobacterium tuberculosis
@en
P2093
Farzad Noubary
Jason R Andrews
Rodrigo Cerda
P2860
P304
P356
10.1093/CID/CIR951
P407
P577
2012-01-19T00:00:00Z